North America Travel Vaccines Market Forecast to 2028

Report Code : BMIRE00025499 | Region : North America | Industry : Pharmaceuticals | Published Date : 28/Jul/2022
North America Travel Vaccines Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Hepatitis A, Hepatitis B, Meningococcal Vaccines, and Others) and Application (Domestic Travel and Outbound Travel)

The travel vaccines market in North America is expected to grow from US$ 1,276.32 million in 2021 to US$ 2,503.59 million by 2028; it is estimated to grow at a CAGR of 10.1% from 2021 to 2028.

Travelling and tourism have become an integral part of the human lifestyle. Travelling and tourism have not only added a change in the ongoing routine of people but have also offered opportunities to explore different cultures, traditions, spiritualism, rural and ethnic tourism, wellness and health holidays, and many more worldwide. Travelling outside the country requires immunization as a safety and precautionary measure to avoid spreading infections. Various countries have policies to protect their citizens from travel-associated infections. The above estimates suggest that travel and tourism will increase in the coming years. Furthermore, economic crises and demand for better job opportunities contributed to the increasing travel and tourism across the region. Thus, the increasing travel and tourism propel the demand for travel vaccines. Furthermore, economic crises and demand for better job opportunities have contributed to the increasing travel and tourism worldwide. Thus, the increasing travel and tourism propel the demand for travel vaccines.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the North America travel vaccines market . The North America travel vaccines market is expected to grow at a good CAGR during the forecast period.

North America Travel Vaccines Market Revenue and Forecast to 2028 (US$ Million)

North America Travel Vaccines Market Segmentation

North America travel vaccines market is segmented into product, application, and country. The North America travel vaccines market, by product, is segmented into hepatitis A, hepatitis B, meningococcal vaccines, and others. In 2021, the others segment held the largest share of the market. By application, the North America travel vaccines market is segmented into domestic and outbound travel. In 2021, the outbound travel segment held the largest share of the market. Based on country, the North America travel vaccines market is segmented into the US, Canada, and Mexico. The US held the largest market share in 2021.

Abbott; Dynavax Technologies; Emergent BioSolutions Inc.; GlaxoSmithKline plc; Merck & Co., Inc.; Novartis AG; Pfizer Inc.; Sanofi; and Valneva SE are among the leading companies in the travel vaccines market in the region.

The List of Companies - North America Travel Vaccines Market

● Abbott

● Dynavax Technologies

● Emergent BioSolutions Inc.

● GlaxoSmithKline plc

● Merck & Co., Inc.

● Novartis AG

● Pfizer Inc.

● Sanofi

● Valneva SE.

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 North America Travel Vaccines Market – By Product

1.3.2 North America Travel Vaccines Market – By Application

1.3.3 North America Travel Vaccines Market – By Country

2. North America Travel Vaccines Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. North America Travel Vaccines Market– Market Landscape

4.1 Overview

4.2 North America PEST Analysis

4.3 Expert Opinion

5. North America Travel Vaccines Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Surging Travel and Tourism

5.1.2 Rising Incidences of Infectious Diseases

5.2 Market Restraints

5.2.1 High Cost of Travel Vaccines

5.3 Market Opportunities

5.3.1 Rising Awareness Regarding Vaccines

5.4 Future Trends

5.4.1 Never-ending Demand for Vaccines

5.5 Impact Analysis

6. Travel Vaccines Market – North America Analysis

6.1 North America Travel Vaccines Marker Revenue Forecast and Analysis

7. North America Travel Vaccines Market Analysis – By Product

7.1 Overview

7.2 North America Travel Vaccines Market Revenue Share, by Product (2021 and 2028)

7.3 Hepatitis A

7.3.1 Overview

7.3.2 Hepatitis A: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

7.4 Hepatitis B

7.4.1 Overview

7.4.2 Hepatitis B: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

7.5 Meningococcal Vaccines

7.5.1 Overview

7.5.2 Meningococcal Vaccines: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

7.6 Others

7.6.1 Overview

7.6.2 Others: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

8. North America Travel Vaccines Market Analysis – By Application

8.1 Overview

8.2 North America Travel Vaccines Market Revenue Share, by Application (2021 and 2028)

8.3 Domestic Travel

8.3.1 Overview

8.3.2 Domestic Travel: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

8.4 Outbound Travel

8.4.1 Overview

8.4.2 Outbound Travel: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

9. North America Travel Vaccines Market – Country Analysis

9.1 North America: Travel Vaccines Market

9.1.1 North America: Travel Vaccines Market, by Country, 2020 & 2028 (%)

9.1.1.1 US: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.1.1.1 US: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.1.1.2 US: Travel Vaccines Market, by Product, 2019–2028 (US$ ‘Million)

9.1.1.1.3 US: Travel Vaccines Market, by Application, 2019–2028 (US$ ‘Million)

9.1.1.2 Canada: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.1.2.1 Canada: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.1.2.2 Canada: Travel Vaccines Market, by Product, 2019–2028 (US$ ‘Million)

9.1.1.2.3 Canada: Travel Vaccines Market, by Application, 2019–2028 (US$ ‘Million)

9.1.1.3 Mexico: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.1.3.1 Mexico: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.1.3.2 Mexico: Travel Vaccines Market, by Product, 2019–2028 (US$ ‘Million)

9.1.1.3.3 Mexico: Travel Vaccines Market, by Application, 2019–2028 (US$ ‘Million)

10. Travel Vaccines Market–Industry Landscape

10.1 Overview

10.2 Growth Strategies in the Travel Vaccines Market, (%)

10.3 Organic Developments

10.3.1 Overview

10.4 Inorganic Developments

10.4.1 Overview

11. Company Profiles

11.1 GlaxoSmithKline plc.

11.1.1 Key Facts

11.1.2 Business Description

11.1.3 Products and Services

11.1.4 Financial Overview

11.1.5 SWOT Analysis

11.1.6 Key Developments

11.2 Merck & Co., Inc.

11.2.1 Key Facts

11.2.2 Business Description

11.2.3 Products and Services

11.2.4 Financial Overview

11.2.5 SWOT Analysis

11.2.6 Key Developments

11.3 Sanofi

11.3.1 Key Facts

11.3.2 Business Description

11.3.3 Products and Services

11.3.4 Financial Overview

11.3.5 SWOT Analysis

11.3.6 Key Developments

11.4 Novartis AG

11.4.1 Key Facts

11.4.2 Business Description

11.4.3 Products and Services

11.4.4 Financial Overview

11.4.5 SWOT Analysis

11.4.6 Key Developments

11.5 Pfizer Inc.

11.5.1 Key Facts

11.5.2 Business Description

11.5.3 Products and Services

11.5.4 Financial Overview

11.5.5 SWOT Analysis

11.5.6 Key Developments

11.6 Dynavax Technologies

11.6.1 Key Facts

11.6.2 Business Description

11.6.3 Products and Services

11.6.4 Financial Overview

11.6.5 SWOT Analysis

11.6.6 Key Developments

11.7 Emergent BioSolutions Inc.

11.7.1 Key Facts

11.7.2 Business Description

11.7.3 Products and Services

11.7.4 Financial Overview

11.7.5 SWOT Analysis

11.7.6 Key Developments

11.8 Abbott

11.8.1 Key Facts

11.8.2 Business Description

11.8.3 Products and Services

11.8.4 Financial Overview

11.8.5 SWOT Analysis

11.8.6 Key Developments

11.9 Valneva SE.

11.9.1 Key Facts

11.9.2 Business Description

11.9.3 Products and Services

11.9.4 Financial Overview

11.9.5 SWOT Analysis

11.9.6 Key Developments

12. Appendix

12.1 About the Insight Partners

12.2 Glossary of Terms

LIST OF TABLES.

Table 1. US: Travel Vaccines Market, by Product – Revenue and Forecast to 2028 (US$ ‘Million)

Table 2. US: Travel Vaccines Market, by Application – Revenue and Forecast to 2028 (US$ ‘Million)

Table 3. Canada: Travel Vaccines Market, by Product – Revenue and Forecast to 2028 (US$ ‘Million)

Table 4. Canada: Travel Vaccines Market, by Application – Revenue and Forecast to 2028 (US$ ‘Million)

Table 5. Mexico: Travel Vaccines Market, by Product – Revenue and Forecast to 2028 (US$ ‘Million)

Table 6. Mexico: Travel Vaccines Market, by Application – Revenue and Forecast to 2028 (US$ ‘Million)

Table 7. Organic Developments Done by Companies

Table 8. Inorganic Developments Done by Companies

Table 9. Glossary of Terms, North America Travel vaccines Market

The List of Companies - North America Travel Vaccines Market

● Abbott

● Dynavax Technologies

● Emergent BioSolutions Inc.

● GlaxoSmithKline plc

● Merck & Co., Inc.

● Novartis AG

● Pfizer Inc.

● Sanofi

● Valneva SE.

Reason To Buy

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the MEA industrial air filter market.

● Highlights key business priorities in order to assist companies to realign their business strategies.

● The key findings and recommendations highlight crucial progressive industry trends in the MEA industrial air filter market, thereby allowing players across the value chain to develop effective long-term strategies.

● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

● Scrutinize in-depth MEA market trends and outlook coupled with the factors driving the market, as well as those hindering it.

● Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

AVAILABLE CUSTOMIZATION RESEARCH METHODOLOGY REQUEST FOR TOC FREE SAMPLE REPORT
CHOOSE LICENCE TYPE
(North America Travel Vaccines Market Forecast to 2028 )
  • Single User Price $3,000$2,400
  • Site Price $4,000$3,200
  • Enterprise Price $5,000$4,000
Buy Now Add to Cart
REQUEST FOR TOC
SPEAK TO ANALYST
FREE SAMPLE
REPORT
INQUIRE BEFORE
BUYING
TOP
Quick Enquiry